A study co-authored by Yale SOM’s James Choi tested a variety of text messages to prompt people to get flu vaccines, offering one potential tool to encourage those who aren’t rushing to get a COVID shot.
There is another epidemic we cannot lose sight of: the opioid epidemic, which has become only more acute in the United States and elsewhere amidst the disruptions and stress caused by COVID-19.
The price of a single Bitcoin is up more than 700% since the beginning of 2020, defying years of predictions of a crash. We asked Prof. Aleh Tsyvinski, professor of economics at Yale, to shed some light on the continuing phenomenon.
We asked Yale SOM leadership expert Jeffrey Sonnenfeld, author of a landmark study of CEO succession, how Amazon will be changed by the departure of its founder.
We asked Yale SOM’s Kelly Shue, an expert in behavioral economics and empirical corporate finance, to explain what the GameStop phenomenon might mean for the balance of power on Wall Street.
A year into the COVID-19 pandemic, vaccines are a reality—and now we face the logistical and medical complications of inoculating a vast population while infection rages and the virus mutates. We asked Yale SOM’s Dr. Howard Forman, a public authority on the pandemic, for an update.
A new federal law prevents patients from being billed by out-of-network doctors after being treated in an in-network hospital. We asked Prof. Fiona Scott Morton, whose research helped bring the practice to light, what the new law will mean for patients and healthcare costs.
After an extraordinarily difficult year, we are all looking for respite from the isolation and uncertainty of pandemic life. We asked Marissa King, who studies personal and team dynamics, to share some quick tips for making this year’s holiday season a little brighter.
Prof. Andrew Metrick, director of the Yale Program on Financial Stability, says that the four emergency lending programs recently shut down by Treasury Secretary Steven Mnuchin are an insurance policy that may be badly needed in 2021.
Pfizer’s announcement that its experimental COVID-19 vaccine appears to be more than 90% effective has provided hope for relief from the increasingly calamitous onslaught of the virus. We asked Yale SOM’s Dr. Howard Forman about next steps.